A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/164
A61K 9/22 (2006.01) A61K 9/20 (2006.01) A61K 9/30 (2006.01)
Patent
CA 1140466
Abstract A sustained release pharmaceutical composition in table-t form comprises an effective amount of an orally- active therapeutic agent, 0.8 to 1. 6% by weight of a release controlling agent and 1.0 to 7.5% by weight of an erosion promoting agent, the relative amounts of the components being such that a criticality factor calculated according to equation I lies in the range 20 to 450. Equation 1 is Image I wherein CF is the criticality factor, CA is the. amount of therapeutic agent per tablet in milligrams divided by the amount of release controlling agent per tablet in milli- grams and CS is the amount of erosion promoting agent per tablet in milligrams divided by the amount of release controlling agent per-tablet in milligrams, Suitable therapeutic agents include acetylsalicylic acid, ibuprofen and flurbiprofen. A preferred release controlling agent is cellulose acetate phthalate and a preferred erosion promoting agent is corn starch.
368219
Dunn James M.
Lampard John F.
Boots Company Limited (the)
Stewart & Kolash Ltd
LandOfFree
Pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1162438